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LoS was founded in October 
2000 not as a publisher, but 
as a grassroots movement of 
researchers who believed that the 
results of the global research enterprise 
should be a freely available public 
resource. So why did PLoS become a 
publisher, and what are we doing in 
this role to serve the world’s varying 
biomedical researchers and clinicians?
At its inception, the ﬁ  rst action by 
PLoS was to encourage scientiﬁ  c and 
medical journal publishers to make 
the archival research literature freely 
available. An open letter, signed by 
almost 34,000 scientists from 180 
countries, urged publishers to deposit 
copies of their research articles in 
a full text public repository, such as 
PubMed Central, within six months of 
publication. Sadly, the vast majority of 
publishers declined to deposit their 
works—a depressing situation that 
continues to this day.
We concluded that the only way 
forward was to publish our own 
journals. These would provide an 
alternative, open-access venue for 
important discoveries in science 
and medicine and would serve as a 
model for showing that open-access 
publication is viable.
The ﬁ  rst phase of our life as a 
publisher involved launching our 
two ﬂ  agship journals—PLoS Biology 
in October 2003 and PLoS Medicine 
in October 2004. These two journals 
provide an open-access alternative to 
the best subscription journals in the life 
sciences and medicine, respectively. 
These ﬁ  rst journals have helped to 
put open access on the map. In the 18 
months since we started as a publisher 
not only have many researchers 
embraced these ﬂ  edgling journals as a 
top tier “home” for their work, but also 
there has been growing international 
support for open-access initiatives. 
For example, 55 institutions 
worldwide have so far signed the 
Berlin Declaration on Open Access 
to Knowledge in the Science and 
Humanities. Beginning this month, 
researchers who are funded by the 
United States National Institutes 
of Health are being asked by the 
agency to deposit a copy of their 
accepted research papers into PubMed 
Central. And in the United Kingdom, 
the Wellcome Trust is making it a 
requirement of its grant conditions that 
Wellcome Trust–funded researchers 
deposit an electronic version of 
their manuscripts in a UK portal of 
PubMed Central within six months of 
publication. 
PLoS is now entering its second 
phase as a publisher, in which we 
launch the ﬁ  rst three PLoS community 
journals. The case for launching these 
journals was compelling—we wanted 
to serve three research communities 
that had few open-access alternatives 
to the subscription journals in their 
ﬁ  eld. As a result, we are launching 
PLoS Computational Biology (www.
ploscompbiol.org), a collaboration 
between PLoS and the International 
Society for Computational Biology, 
scheduled to start publishing in June 
2005; PLoS Genetics (www.plosgenetics.
org), scheduled for July 2005; and PLoS 
Pathogens (www.plospathogens.org), 
scheduled for September 2005. 
With the arrival of the community 
journals, we are providing a greater 
range of open-access venues for 
researchers who wish to ensure that 
anyone can read, use, and build 
on their work. Unlike PLoS Biology 
and PLoS Medicine, which are run by 
PLoS editorial staff, each community 
journal is run by the community 
itself—that is, by an academic editor-
in-chief and editorial board, with 
production support from PLoS staff. 
The community-led nature of the new 
journals, coupled with a business model 
in which publication costs are borne 
largely by publication charges, provides 
an example for other journals that wish 
to transition to open access.
When submitting their work to PLoS, 
how do researchers and clinicians 
distinguish between PLoS Medicine 
and the PLoS community journals? 
PLoS Medicine remains committed to 
publishing the best medical research 
that is relevant to a broad international 
community of clinicians and 
researchers. The community journals 
are aimed at a more specialized 
audience. PLoS Pathogens, for example, 
will publish basic scientiﬁ  c research 
that “signiﬁ  cantly advances the 
understanding of pathogens and how 
they interact with their host organisms.” 
But we also think that PLoS Medicine 
readers will ﬁ  nd much of interest in 
the community journals, and vice versa, 
and we will cross-link between articles 
in the different journals.
The different PLoS journals will 
be editorially independent and 
submissions will remain conﬁ  dential to 
each journal. But if an author would 
like a manuscript that is not thought 
to be appropriate by one journal to be 
passed on to another, along with the 
reviewers’ reports and their identities, 
we are happy to cooperate, subject 
to the permission of the reviewers. 
This can help to speed up the review 
process.
As we roll out the new community 
journals, we are already planning the 
third phase of our life as a publisher—
the creation of an online repository 
for all technically sound research 
reports in both biology and medicine, 
including clinical trial reports. It is an 
ambitious plan, but one that we believe 
will provide authors with more choices 
and in the end, an open-access venue 
for the widest range of research.
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